Conclusion
- Development of a Small, Implantable Right Ventricular Assist Device

The initial in vitro testing met the design criteria for the new, implantable DexAide RVAD. Initial in vivo testing is under way, which will be followed by preclinical readiness testing and a pilot clinical trial in this 5-year program.

Acknowledgments

This study was supported by a Bioengineering Research Partnerships (BRP) grant 5R01HL074896, issued by the National Heart, Lung, and Blood Institute, National Institutes of Health.

Footnotes

Presented at the 51st annual conference of the American Society for Artificial Internal Organs, Washington, DC, June 9, 2005

Disclosures: None

References

Discussion

Go to page: 1 2 3 4 5 6 7 8

rating: 0.00 from 0 votes | updated on: 10 Aug 2006 | views: 5732 |

share this article | email to friends

suggest a revision
print this page
print the whole article

Rate article:

Login

Conclusion - Development of a Small, Implantable Right Ventricular Assist Device

Conclusion
- Development of a Small, Implantable Right Ventricular Assist Device